Abstract
Glucagon-like peptide-1 (GLP-1), which is an endogenous insulinotropic peptide that can stimulate islet cells to secret insulin, is a promising new drug candidate for the treatment of type 2 diabetes. However, due to the very short half-life of this peptide, the clinical value of GLP-1 is restricted. A GLP-1 peptide analog that had been altered by deletion of five amino acids from the C-terminus (sGLP-1) was selected and investigated in vivo for the therapeutic effect on GK rats with type II DM (T2DM). The results revealed that sGLP-1 exhibited decreased blood glucose-lowering ability compared to GLP-1 in the first week, as measured after once-daily administration. However, after drug administration for 2 weeks, the blood glucose-lowering effect of sGLP-1 became superior to that of GLP-1. sGLP-1 reduced apoptosis of the old islets, enhanced insulin production, and promoted new islets replication. sGLP-1 is a shorter but more efficient GLP-1 analog for type 2 diabetes management. Because sGLP-1 prolonged the proliferation and recovery of islet cells, the ability to maintain blood glucose (BG) within a normal range was still present 2 weeks after drug withdrawal. These results confirmed the importance of the C-terminus of GLP-1 m...Continue Reading
References
Apr 1, 1990·Endocrinology·D GefelG C Weir
Mar 1, 1989·Diabetes·G C WeirJ F Habener
Dec 1, 1989·Endocrinology·S SuzukiK Yamashita
Mar 1, 1988·The Journal of Endocrinology·R Göke, J M Conlon
Dec 5, 1987·Lancet·B KreymannS R Bloom
Apr 21, 1983·Nature·G I BellG T Mullenbach
Jun 15, 1993·European Journal of Biochemistry·R MentleinW E Schmidt
May 1, 1993·Diabetes·C OrskovJ J Holst
Mar 31, 1998·Diabetes·D J Drucker
Jul 17, 1999·Trends in Endocrinology and Metabolism : TEM·J J Holst
Mar 13, 2002·The Journal of Clinical Endocrinology and Metabolism·Josephine M EganDariush Elahi
Nov 1, 2002·The Journal of Biological Chemistry·Yazhou LiDaniel J Drucker
Feb 28, 2003·Diabetes·Jung-Guk KimDaniel J Drucker
Apr 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Torsten P VahlDavid A D'Alessio
Jul 2, 2003·Regulatory Peptides·Máire E DoyleJosephine M Egan
Dec 3, 2003·Endocrinology·Daniel J Drucker
Mar 31, 2005·Biochemical and Biophysical Research Communications·Søren BregenholtJacob S Petersen
Jun 25, 2005·Regulatory Peptides·Martin BeinbornAlan S Kopin
Dec 3, 2005·The Journal of Clinical Investigation·David A D'AlessioRandy J Seeley
Oct 14, 2006·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·M A NauckUNKNOWN NN2211-1499 Study Group
Citations
May 12, 2012·International Journal of Endocrinology·Elena TarabraMichael Khan
Nov 3, 2010·Annals of the New York Academy of Sciences·Jeremy A Lavine, Alan D Attie
Jan 29, 2013·Peptides·Guo-jiang HouZhu-fang Shen